Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
In this expanded collection, we present companies harnessing the power of artificial intelligence for the development of cutting-edge tools and novel approaches to accelerate drug discovery and research.
Complex, genetic and rare diseases continue to pose challenges globally, but new targeted approaches and personalized therapies are accelerating progress in the field. Here we present rare diseases therapies in development.
Development in antibody technologies continues to diversify, providing a rich pipeline of new and innovative therapeutics. In this collection, we present antibody-focused companies, along with their technologies and therapies.
Image: Credit: Science Picture Co / Alamy Stock Photo
From rapid candidate selection, to fewer clinical trials and faster market approval, artificial intelligence approaches are helping to accelerate and improve the efficiency of the drug development process, whilst significantly reducing costs. Here we present a number of companies working in the field.